Audited final results for year ended 30 June 2016
Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR)
21 November 2016
AIM: FIPP
Frontier IP Group plc
("Frontier IP", the "Group" or "the Company")
Audited final results for the year ended 30 June 2016
Frontier IP Group Plc is focused on the commercialisation of intellectual property
Financial Highlights
· Total revenue increased by 27% to £2,030,000 (2015: £1,591,000) - reflecting an unrealised profit on the revaluation of investments of £1,809,000 (2015: £1,421,000)
· Revenue from services increased by 30% to £221,000 (2015: £170,000)
· Profit before tax increased by 75% to £1,131,000 (2015: £647,000)
· Basic earnings per share increased to 4.08p (2015: 2.76p)
· Cash balances at 30 June 2016 of £771,000 (2015: £636,000)
· Net assets per share as at 30 June 2016 of 24.9p (2015: 20.9p)
Operational Highlights
· Placing raised £1,003,000 (gross)
· Commercialisation agreement signed with first Portuguese University - Évora University
· Post period-end, further expansion into the European market through agreement with Universidade NOVA de Lisboa, Faculty of Science and Technology, Portugal
Portfolio
· Fair value of portfolio companies increased by 65% to £4,651,000 (2015: £2,812,000)
· Portfolio companies PulsiV Solar Limited and Nandi Proteins Limited secured funding
· ex scientia Limited secured partnership with Evotec AG
Neil Crabb, Chief Executive Officer of Frontier IP, said:
"The Group is making good progress in line with its strategy. I am particularly pleased to report the growth in value of our portfolio. We have expanded our network of universities and have increased the size of the equity stakes we are entitled to receive. Our pipeline continues to show healthy expansion, which we expect to convert to growth in our Core Portfolio in the current financial year. We are also seeing strong commercial progress in our existing Core Portfolio, together building the potential for further uplift in value."
Enquiries
|
Frontier IP Group Plc |
|
T: 0131 240 1251 |
|
Neil Crabb, Chief Executive |
|
|
|
Company website: www.frontierip.co.uk
|
|
|
|
Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker) |
|
T: 020 7894 7000 |
|
David Foreman, Catherine Leftley, Corporate Finance |
|
|
|
David Banks, Corporate Broking |
|
|
|
|
|
|
|
Peterhouse Corporate Finance Limited (Joint Broker) |
|
T: 020 7469 0935 |
|
Lucy Williams |
|
|
|
|
|
|
|
Kreab |
|
T: 020 7074 1800 |
|
Robert Speed, Matthew Jervois |
|
|
Notes to Editors:
Frontier IP specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property. It establishes formal and informal relationships with sources of exploitable IP, principally universities. Its core business is building and growing a portfolio of equity stakes in spin-out companies by taking an active involvement in the commercialisation and funding of these businesses. Frontier IP currently has seventeen companies in its portfolio, which exploit IP from a range of institutions. www.frontierip.co.uk
Chairman's Statement
Performance
I am pleased to report that Frontier IP has made strong progress during the year in increasing the value of its portfolio and in extending its access to IP, through its first commercialisation partnership in Portugal.
Frontier IP's core strategy is to generate value by providing best-practice IP commercialisation services to institutions and start-ups, by developing a portfolio of companies capable of commercial success and by providing access to capital for these portfolio companies.
Portfolio
We have seen continued progress in our Core Portfolio and we are again pleased to report a significant increase in the fair value of our portfolio overall to £4.6 million, representing a 65% increase over the same period last year. Successful fundraisings for Nandi Proteins Limited ("Nandi") and PulsiV Solar Limited ("PulsiV") and the ex scientia Limited ("ex scientia") partnership with Evotec AG were notable highlights, which together made a significant contribution to the rise in value of our portfolio overall.
IP Sources
In line with our strategy of extending our access to sources of high-quality exploitable research we extended our sources of deal flow with the addition of an agreement with the Universidade de Évora, Portugal ("Évora"). The Iberian market is relatively underserved in the IP commercialisation sector and this partnership has been forged to assist with the spin-off and licensing activities emerging from Évora's research. The agreement with Évora is the first to be established by the Group with a university outside of the UK, and will focus on generating value from research in Energy, Environment, Materials and Agriculture, where Évora has a leading reputation. Our activity in the region was extended, post period-end, with a second commercialisation agreement with the Universidade NOVA de Lisboa, Faculty of Science and Technology. This faculty has particular research strengths in Materials, Environment, Energy, Biotechnology, Conservation and Restoration. The Group will receive a share of equity in each spin-off company created by both institutions, as well as a share in the licensing revenue they receive.
In recognition of our developing a deeper relationship with the University of Cambridge, and the region more-widely, in November 2016 we were pleased to open a Group office in Cambridge. We also expanded the team in Cambridge with a new commercialisation professional, who will be primarily focused on our activity in Cambridge.
Access to Capital
We continued to provide and support access to capital for our Core Portfolio companies during the year, including PulsiV and Nandi, with both completing successful fundraisings. Post year-end, Nandi and Heriot-Watt University, Edinburgh were awarded a £1 million grant from Innovate UK under its "Optimising Food Composition: Fat, Sugar, Salt and Fibre" competition. In line with our portfolio growing and maturing, we continue to extend our industry and financial network, through building an extensive network of funders ranging from institutions, industry investors through to private individuals.
Results
For the year to 30 June 2016, total revenue increased by 27% to £2,030,000 (2015: £1,591,000) as a result of booking an unrealised profit of £1,809,000 (2015: £1,421,000) on the revaluation of investments, principally due to the movement in fair value of three portfolio companies - Nandi, PulsiV and ex scientia. Revenue from services, principally board retainers, fund management fees and license income, increased by 30% to £221,000 (2015: £170,000).
The fair value of our portfolio increased by 65% to £4,651,000 (2015: £2,812,000)
Profit before tax increased by 75% to £1,131,000 (2015: £647,000) reflecting the increased revenue and reduced consultancy costs. The basic earnings per share was 4.08p (2015: 2.76p).
Geopolitical Climate
The UK is facing a period of uncertainty following the outcome of the referendum on UK membership of the EU, with economic uncertainty potentially creating more volatility in financial markets and academic institutions concerned about potential impact on research funding. However, the Group sees opportunity in the context of universities looking to diversify their income streams by increasing commercialisation activity and to demonstrate impact. Furthermore, the ability to continue to protect IP should remain unaffected where the European patent system, for example, is not part of EU law and there has been no suggestion by any party that the UK will leave the European Patent Convention which governs European patents and applications.
Outlook
Looking ahead, we continue to work on a number of new opportunities and intend to continue to grow our portfolio by taking more significant stakes and extending our sources of deal flow. In line with our strategy of broadening the range of capital available to our portfolio companies, we expect to see further portfolio fundraisings during the current financial year.
The Group is seeing excellent progress across its business, both in the UK and internationally, and is well-placed for future growth.
Andrew Richmond
Chairman
Our Performance
Chief Executive Officer's Statement
The Group is making good progress in line with its strategy. I am particularly pleased to report the growth in value of our portfolio, as evidenced by the recent fundraisings. We have expanded our network of universities and, where contracted, have increased the size of the equity stakes we are entitled to receive. We continue to see strong commercial progress in our Core Portfolio building the potential for further uplift in value.
Key Performance Indicators
The key performance indicators for the Group are:
|
KPI |
Description |
2016 Performance |
|
Fair value of the portfolio |
Movement in the value of equity in the portfolio |
£4,651,000 (2015: £2,812,000) |
|
Total revenue |
Growth in the aggregate of revenue from services and change in fair value of the portfolio |
£2,030,000 (2015: £1,591,000) |
|
Profit |
Profit before tax for the year |
£1,131,000 (2015: £647,000) |
|
Net assets per share |
Value of the Group's assets less the value of its liabilities per share outstanding |
24.9p (2015: 20.9p) |
|
Total initial equity in new portfolio companies |
Aggregate percentage equity earned from new portfolio companies during the year |
0% (2015: 80%) |
The Group achieved healthy increases in four out of five of its Key Performance Indicators and we expect significant growth in total initial equity in the coming year. The Chairman's Statement and Operational Review contain further information on progress in the business during the year.
The Group's services revenue for the year to 30 June 2016 increased to £221,000 (2015: £170,000) and, with administrative expenses of £900,000 (2015: £945,000), the Group continues to consume significant cash from operating activities, however the Directors continue to pursue opportunities that will assist in reducing the gap.
Operational Review
Corporate
Frontier IP completed a placing in March 2016 to support the development and growth of its relationships, advisory roles and portfolio companies. The placing comprised 4,177,500 new ordinary shares of 10p at a price of 24p per share, raising £1,003,000 before expenses.
Portfolio - Key Developments
During the year two of our portfolio companies PulsiV and Nandi completed successful fundraisings.
PulsiV
In October 2015, PulsiV raised £0.5 million, valuing PulsiV at £5 million with Frontier IP retaining an 18.9% holding in the issued share capital. PulsiV, which spun out from Plymouth University, has developed new technology which significantly improves the energy efficiency of photovoltaic solar panels. It does this by maximising the energy generated by the system's inverters, which convert the energy harvested for supply to the grid. Results from PulsiV's first prototype show average increases of up to 30% in energy generation when compared with conventional inverter technology. The technology can be integrated into new systems or retrofitted to existing solar panels. The fundraising has enabled PulsiV to accelerate product development, enabling further prototyping and testing in preparation for the initial production of micro-inverters containing its technologies. According to a recent GTM Research report, Global PV Inverter and MLPE Landscape 2016, global shipments of solar PV inverters will reach 90 gigawatts by 2020 (59.7 gigawatts were shipped in 2015). This represents an average annual growth rate of 11 percent between 2016 and 2020.
Nandi
Nandi's most recent fundraising, in March 2016, raised £250,000 from new and existing investors at a valuation of £7.57 million, twice the price per share of the previous fundraising in November 2014. Nandi, which spun out from Heriot‐Watt University, Edinburgh, is commercialising a patented protein process technology which can reduce sugars, fats and emulsifiers in processed food without adversely impacting taste and texture. Nandi's technology is being rolled out at a time when food companies are under increasing legislative pressure to reduce the level of these ingredients in their products. Nandi's technology enables food industry customers to remain competitive in response to healthier eating trends using sustainable, naturally‐occurring proteins in food manufacture. The funding is enabling Nandi to develop further its relationships with multinational food companies, where strong interest has already been shown, and a further funding round is expected in the current financial year 2016/17 to continue this progress.
ex scientia
We were pleased to note the commercial progress at ex scientia during the year and the significant increase in value of our minor equity stake. In particular, we welcomed the announcement of its partnership with Evotec AG, a collaboration with the objective to discover and develop first-in-class bispecific small molecule immuno-oncology therapies.
Sources of IP
In the year we added an agreement with the Universidade de Évora. This agreement is the first to be established by the Group with a university outside of the UK. Frontier IP and Évora, which has a leading reputation in Energy, Environment, Materials and Agriculture, will work together to maximise the commercial value of IP developed within or owned by the University. The Group will receive a share of the equity in each spin-off company created by the University, as well as a share in the licensing revenue it receives.
Portugal has a strong research base in certain key sectors relevant to the Group's activity, in particular in sustainable energy and food and agriculture, which complements the Group's relationships with utility companies in the region - EDP (Energias de Portugal) and Iberdrola. The Group believes that the region offers significant under-exploited opportunity, relative to the UK which has a strong and mature IP commercialisation market, where Portugal is actively seeking to widen access to early-stage funding and commercialisation expertise.
In line with our business model, our strategy is to seek to increase both the size of equity stakes we receive from our sources of IP and extend our portfolio pipeline for sources of high-quality IP. We continually review our partnerships, both formal and informal, for quality of dealflow and economic viability. This approach ensures that effort is focused where it is most effective and there is most potential value. The opening of a base in Cambridge is a clear demonstration of our commitment to this approach. Our focus on creating a portfolio of companies, where we are actively involved and hold a significant stake capable of delivering substantial value, has led us to opt not to renew our partnership with University of Dundee which came to the end of its 10-year term, post-period-end, in November 2016.
We were also pleased to announce, post period-end, the securing of a commercialisation agreement with the Faculty of Science and Technology within the Universidade NOVA de Lisboa ("FCT Nova"), Portugal, Frontier IP's second in Portugal and reflecting the Group's view that there is significant opportunity in the region. The Universidade NOVA de Lisboa is a research-intensive university (QS Top Universities 2016) and FCT Nova has particular research strengths in Engineering, Materials, Energy and Life Sciences. Frontier IP and FCT Nova will work together to maximise the commercial value of intellectual property developed within or owned by FCT Nova. Frontier IP will receive a share of equity in each spin-off company created by FCT Nova, as well as a share in the licensing revenue it receives.
We are seeing high-quality research with commercial application coming through from our formal and informal relationships, in particular from Plymouth and Cambridge universities, where we have significantly increased the spinout equity we receive relative to our historic relationships.
Access to Funding
We continue to extend and make use of our network in managing funding rounds for our portfolio companies, with a particular focus on our Core Portfolio. The recent investments in Nandi and PulsiV were a successful demonstration of this approach. Frontier IP manages and builds an extensive network of funders ranging from institutions, industry investors through to private individuals.
Financial Review
Key Highlights
Profit after tax for the Group for the year to 30 June 2016 was £1,131,000 (2015: £647,000). This result includes a net unrealised profit on the revaluation of investments of £1,809,000 (2015: £1,421,000) and reflects an increase in services revenue to £221,000 (2015: £170,000) and a reduction in administrative expenses to £900,000 (2015: £945,000).
The value of the Group's investments increased to £4,673,000 (2015: £2,859,000). Net assets increased to £7,668,000 (2015: £5,557,000) reflecting the proceeds of the £1,003,000 (gross) placing and the profit for the year.
In March 2016, the Company conducted a placing of 4,177,500 new ordinary shares of 10p for cash at a price of 24p per share raising £1,003,000 before expenses.
Revenue
Total revenue for the year to 30 June 2016 increased 27% to £2,030,000 (2015: £1,591,000). Revenue from services increased 30% to £221,000 (2015: £170,000). The Group's net unrealised profit on the revaluation of investments increased 27% to £1,809,000 (2015: £1,421,000). Unrealised gains on revaluation of investments of £2,045,000 (2015: £1,531,000) were offset by impairments of £236,000 (2015: £110,000). £786,000 of the gain relates to Nandi Proteins Limited and £331,000 to PulsiV Solar Limited, both of whom completed a fundraising during the year, and £928,000 of the gain relates to ex scientia Limited.
Administrative Expenses
Administrative expenses decreased by 5% to £900,000 (2015: £945,000). The decrease is primarily due to savings in consultancy fees following the termination of a contract.
Earnings Per Share
Basic earnings per share was 4.08p (2015: 2.76p). Diluted earnings per share was 4.04p (2015: 2.71p)
Statement of Financial Position
The principal items in the statement of financial position at 30 June 2016 are goodwill £1,966,000 (2015: £1,966,000) and financial assets at fair value through profit and loss, principally holdings in portfolio companies, £4,673,000 (2015: £2,859,000). The carrying value of these items is determined by the Directors using their judgement when applying the Group's accounting policies. The considerations taken into account by the Directors when reviewing the carrying value of goodwill are detailed in Note 9. The matters taken into account when assessing the fair value of the portfolio companies are detailed in the accounting policy on investments.
The Group had net current assets at 30 June 2016 of £883,000 (2015: £701,000). The current assets at 30 June 2016 include debtors of £88,000 which are more than 90 days overdue, of which £82,000 is due from Nandi. The non-current trade receivables of £144,000 are also due from Nandi. Nandi is about to commence an additional fundraising and the Directors are confident that Nandi will be able to raise sufficient funds to finance both Nandi's business plan and to commence payment of the debt over an agreed eighteen months.
Net assets of the Group increased to £7,668,000 at 30 June 2016 (30 June 2015: £5,557,000). The number of issued ordinary shares also increased to 30,778,520 at 30 June 2016 (2015: 26,601,020) resulting in net assets per share of 24.9p (2015: 20.9p).
Cash
The Group's cash balances increased during the year by £135,000 to £771,000 at 30 June 2016. This was as a result of a placing of new shares which raised £947,000 net of expenses. The cash generated by the share placing was used to fund the operation of the business.
Consolidated Statement of Comprehensive Income
For the year ended 30 June 2016
|
|
|
2016 |
|
2015 |
|
|
Notes |
£'000 |
|
£'000 |
|
Revenue |
|
|
|
|
|
Revenue from services
Other operating income Unrealised profit on the revaluation of investments |
|
221
1,809 |
|
170
1,421 |
|
|
|
|
|
|
|
Total revenue |
|
2,030 |
|
1,591 |
|
|
|
|
|
|
|
Administrative expenses |
|
(900) |
|
(945) |
|
|
|
|
|
|
|
Profit from operations |
|
1,130 |
|
646 |
|
|
|
|
|
|
|
Interest income on short term deposits |
|
1 |
|
1 |
|
|
|
|
|
|
|
Profit from operations and before tax |
|
1,131 |
|
647 |
|
|
|
|
|
|
|
Taxation |
3 |
- |
|
- |
|
|
|
|
|
|
|
Profit and total comprehensive income attributable to |
|
|
|
|
|
the equity holders of the parent |
|
1,131 |
|
647 |
|
|
|
|
|
|
|
Profit per share attributable to the equity holders of the Company: |
|
|
|
|
|
Basic earnings per share |
4 |
4.08p |
|
2.76p |
|
Diluted earnings per share |
4 |
4.04p |
|
2.71p |
All of the Group's activities are classed as continuing.
Consolidated Statement of Financial Position
At 30 June 2016
|
|
|
2016 |
|
2015 |
|
|
Notes |
£'000 |
|
£'000 |
|
Assets |
|
|
|
|
|
Non-current assets |
|
|
|
|
|
Tangible fixed assets |
|
2 |
|
2 |
|
Goodwill |
|
1,966 |
|
1,966 |
|
Financial assets at fair value through profit and loss |
5 |
4,673 |
|
2,859 |
|
Trade receivables |
|
144 |
|
29 |
|
|
|
6,785 |
|
4,856 |
|
Current assets |
|
|
|
|
|
Trade receivables and other current assets |
|
223 |
|
188 |
|
Cash and cash equivalents |
|
771 |
|
636 |
|
|
|
994 |
|
824 |
|
Total assets |
|
7,779 |
|
5,680 |
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
Current liabilities |
|
|
|
|
|
Trade and other payables |
|
(111) |
|
(123) |
|
|
|
(111) |
|
(123) |
|
|
|
|
|
|
|
Net assets |
|
7,668 |
|
5,557 |
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
Called up share capital |
|
3,078 |
|
2,660 |
|
Share premium account |
|
5,729 |
|
5,200 |
|
Reverse acquisition reserve |
|
(1,667) |
|
(1,667) |
|
Share based payment reserve |
|
78 |
|
45 |
|
Retained earnings |
|
450 |
|
(681) |
|
Total equity |
|
7,668 |
|
5,557 |
Consolidated Statement of Changes in Equity
For the year ended 30 June 2016
|
|
Share capital |
Share premium account |
Reverse acquisition reserve |
Share- based payment reserve |
Retained earnings |
Total equity attributable to equity holders of the Company |
|
|
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
|
|
|
|
|
|
|
|
At 1 July 2014 |
2,253 |
4,794 |
(1,667) |
125 |
(1,436) |
4,069 |
|
|
|
|
|
|
|
|
|
Issue of shares |
407 |
406 |
- |
- |
- |
813 |
|
Share-based payments |
- |
- |
- |
28 |
- |
28 |
|
Transfer on expiry of warrants in prior year |
- |
- |
- |
(108) |
108 |
- |
|
Profit/total comprehensive income for the year |
- |
- |
- |
- |
647 |
647 |
|
|
|
|
|
|
|
|
|
At 30 June 2015 |
2,660 |
5,200 |
(1,667) |
45 |
(681) |
5,557 |
|
|
|
|
|
|
|
|
|
Issue of shares |
418 |
529 |
- |
- |
- |
947 |
|
Share-based payments |
- |
- |
- |
33 |
- |
33 |
|
Profit/total comprehensive income for the year |
- |
- |
- |
- |
1,131 |
1,131 |
|
|
|
|
|
|
|
|
|
At 30 June 2016 |
3,078 |
5,729 |
(1,667) |
78 |
450 |
7,668 |
Consolidated Statement of Cash Flows
For the year ended 30 June 2016
|
|
2016 |
2015 |
|
|
£'000 |
£'000 |
|
|
|
|
|
Cash flows from operating activities |
|
|
|
Cash used in operations |
(805) |
(730) |
|
Taxation paid |
- |
- |
|
Net cash used in operating activities |
(805) |
(730) |
|
|
|
|
|
Cash flows from investing activities |
|
|
|
Purchase of tangible fixed assets |
(2) |
(1) |
|
Purchase of financial assets at fair value through profit and loss |
(5) |
(33) |
|
|
|
|
|
Net cash used in investing activities |
(7) |
(34) |
|
|
|
|
Cash flows from financing activities |
|
|
Proceeds from issue of equity shares |
1,003 |
854 |
Costs of share issue |
(56) |
(41) |
|
|
|
|
Net cash generated from financing activities |
947 |
813 |
|
|
|
|
Net increase in cash and cash equivalents |
135 |
49 |
|
|
|
|
Cash and cash equivalents at beginning of year |
636 |
587 |
|
|
|
|
Cash and cash equivalents at end of year |
771 |
636 |
Notes
1. General Information
This preliminary announcement was approved for issue by a duly appointed and authorised committee of the Board of Directors on 18 November 2015.
2. Basis of preparation
The financial information set out in this announcement does not constitute statutory financial statements for the year ended 30 June 2016 or 30 June 2015.
The report of the auditor on the statutory financial statements for each of the years ended 30 June 2016 and 30 June 2015 did not contain statements under section 498(2) or (3) of the Companies Act 2006. The statutory financial statements for the year ended 30 June 2015 have been delivered to the Registrar of Companies. The financial statements for the year ended 30 June 2016 will be delivered to the Registrar of Companies following the Company's Annual General Meeting.
The Group's strategy is to develop a growing portfolio of spin-out companies that will provide cash inflows through realisation of investments and in the meantime will make use of the Group's services in return for cash fees. However, based on forecast income and expenditure for the next 12 months, the Group's cash income will be insufficient to cover the Group's expenditure. Consequently, the Group will need to raise additional capital in order to continue in operational existence for at least the next 12 months. The Directors anticipate undertaking an equity placing during the first half of 2017 and intend to seek authority to allot securities at the forthcoming Annual General Meeting in December 2016. The Directors do not expect that the Group's services to its portfolio companies will generate sufficient cash income to cover its non-discretionary outgoings in the medium term and have concluded that it will be necessary to continue to raise capital periodically until such time as the Group's costs and other liabilities can be met from income or realisations. Taking into account the current financing environment and the Group's trading position, the Directors do not regard their ability to raise this capital to be a material uncertainty from a going concern perspective. Consequently the Directors continue to adopt the going concern basis in preparing the group's financial statements.
While the financial information included in this preliminary announcement has been prepared in accordance with the recognition and measurement principles of International Financial Reporting Standards (IFRS) as adopted by the European Union, this announcement does not itself contain sufficient information to comply with IFRS.
3. Taxation
There is no charge to taxation for the year ended 30 June 2016 (2015: Nil) due to the Group making a taxable loss.
The Group's deferred tax assets, other than those relating to short term timing differences, are not recognised in accordance with Group policy.
4. Earnings per share
a) Basic
Basic earnings per share is calculated by dividing the profit attributable to the shareholders of Frontier IP Group
Plc by the weighted average number of shares in issue during the year.
|
|
Profit attributable to shareholders £'000 |
Weighted average number of shares |
Basic earnings per share amount in pence |
|
|
|
|
|
|
Year ended 30 June 2016 |
1,131 |
27,722,650 |
4.08 |
|
|
|
|
|
|
Year ended 30 June 2015 |
647 |
23,414,536 |
2.76 |
b) Diluted
Diluted earnings per share is calculated by adjusting the weighted number of ordinary shares outstanding to assume conversion of all dilutive potential ordinary shares. The Company has only one category of dilutive potential ordinary shares: share options. A calculation is done to determine the number of shares that could have been acquired at fair value (determined as the average annual market value share price of the Company's shares) based on the monetary value of the subscription rights attached to outstanding share options. The number of shares calculated as above is compared with the number of shares that would have been issued assuming the exercise of the share options.
|
|
Profit attributable to shareholders £'000 |
Weighted average number of shares adjusted for share options |
Diluted earnings per share amount in pence |
|
|
|
|
|
|
Year ended 30 June 2016 |
1,131 |
27,998,277 |
4.04 |
|
|
|
|
|
|
Year ended 30 June 2015 |
647 |
23,854,707 |
2.71 |
5. Financial assets at fair value through profit and loss
|
|
2016 |
2015 |
|
|
£'000 |
£'000 |
|
At 1 July 2015 |
2,859 |
1,325 |
|
Additions |
5 |
113 |
|
Fair value increase |
1,809 |
1,421 |
|
At 30 June 2016 |
4,673 |
2,859 |
The investments held are valued individually at fair value in accordance with the Group's accounting policy on investments and have been categorised as being level 3, that is, valued using unobservable inputs. All gains and losses relate to assets held at the year end, and the fair value movement has been shown in the income statement as other operating income.
Financial assets at fair value through profit and loss comprise the following:
|
|
2016 |
2015 |
|
|
£'000 |
£'000 |
|
Limited partnership interests |
22 |
47 |
|
Unquoted equity investments |
4,651 |
2,812 |
|
|
4,673 |
2,859 |
The movement during the year is set out below:
|
Limited Partnership Interests |
2016 |
2015 |
|
|
£'000 |
£'000 |
|
At 1 July |
47 |
34 |
|
Additions during the year |
5 |
33 |
|
Fair value decreases during the year |
(30) |
(20) |
|
At 30 June |
22 |
47 |
|
Unquoted Equity Investments |
2016 |
2015 |
|
|
£'000 |
£'000 |
|
At 1 July |
2,812 |
1,291 |
|
Additions during the year |
- |
80 |
|
Fair value increases during the year |
2,045 |
1,531 |
|
Fair value decreases during the year |
(206) |
(90) |
|
At 30 June |
4,651 |
2,812 |
6. Availability of statutory financial statements
Copies of the full statutory financial statements will be available from the Company's offices at 93 George Street, Edinburgh EH2 3ES no later than 28 November 2016 and are available on its website at www.frontierip.co.uk
This information is provided by RNS
Latest directors dealings
- 7 hours ago Johnson Matthey
- 9 hours ago Galliford Try
- 9 hours ago Galliford Try
- 9 hours ago Centrica
- 10 hours ago Smith & Nephew